MedicationsComments Off on Fulcrum Therapeutics Receives Orphan Drug Designation for Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) and Announces Expanded Patent Portfolio
MedicationsComments Off on Enteris BioPharma Announces Positive Results from Expanded Phase 2a Clinical Trial of Ovarest (oral leuprolide tablet) for Endometriosis
MedicationsComments Off on Many drugs made available via FDA expanded access programs
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok